Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

DIAGNOSTICA STAGO INC

UEI: ND7MY2A4ZUE9CAGE: 0TH01

DIAGNOSTICA STAGO INC is a federal contractor, registered under UEI ND7MY2A4ZUE9 and CAGE code 0TH01. It has been awarded $167,728,860 in federal contracts. Primary work spans Analytical Laboratory Instrument Manufacturing, In-Vitro Diagnostic Substance Manufacturing, and Laboratory Apparatus and Furniture Manufacturing. Top awarding agencies include Department Of Veterans Affairs, Department Of Defense, and Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

ND7MY2A4ZUE9

CAGE Code

0TH01

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationForeign OwnedManufacturer of Goods

NAICS Codes

325413In-Vitro Diagnostic Substance Manufacturing
334516Analytical Laboratory Instrument Manufacturing(Primary)
339112Surgical and Medical Instrument Manufacturing

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Diagnostica Stago Inc. specializes in the manufacturing and support of clinical coagulation analyzers, reagents, and associated consumables for laboratory and point-of-care environments. Their core capabilities center on in-vitro diagnostic systems, including automated coagulation testing platforms ...

Diagnostica Stago Inc. specializes in the manufacturing and support of clinical coagulation analyzers, reagents, and associated consumables for laboratory and point-of-care environments. Their core capabilities center on in-vitro diagnostic systems, including automated coagulation testing platforms such as the STA COMPACT MAX, and the supply of precision reagents for fibrinogen, factor assays, and other hemostasis parameters. The company provides end-to-end solutions encompassing instrument deployment, maintenance, and cost-per-reportable-result service models, demonstrating deep expertise in laboratory workflow integration, quality control compliance, and regulatory adherence for diagnostic instrumentation. Their technical differentiation lies in focused specialization in coagulation diagnostics, offering validated, FDA-cleared systems tailored to high-volume clinical and military laboratory settings. The contractor maintains a sustained relationship with the Department of Veterans Affairs, delivering coagulation testing instrumentation, reagents, and service contracts across multiple Veterans Integrated Service Networks. They also support the Department of Defense with mission-critical coagulation analyzers and associated supplies for military medical facilities, often under sole-source or bridge contracts to ensure uninterrupted diagnostic capacity. Engagement with the Department of Health and Human Services further underscores their role in supporting public health laboratory infrastructure. Diagnostica Stago operates primarily under NAICS 334516 (analytical laboratory instrument manufacturing) and 325413 (in-vitro diagnostic substance manufacturing), positioning them as a niche provider in clinical hemostasis diagnostics. Their market focus is exclusively on laboratory-based diagnostic systems, with no broad diversification into general medical devices or non-coagulation assays. As a 2L entity based in Parsippany, New Jersey, Diagnostica Stago Inc. is a domestic manufacturer with no federal certifications listed. Their government market presence is defined by technical specialization rather than socioeconomic status, serving critical healthcare and defense missions through reliable, regulated diagnostic solutions.

Key Performance Metrics

Awards Count

4,574

All time

Active

80

Currently performing

Completed

4,494

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by Agency Over Time
Awards by Place of Performance

Compete with DIAGNOSTICA STAGO INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for DIAGNOSTICA STAGO INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in DIAGNOSTICA STAGO INC's top NAICS codes and agencies

NAICS: 621511
New
SLED
Statewide Sample Collection, Drug Screen & Confirmatory Testing
Solicitation # J28030
The Department of Judiciary for the State of Hawaii is soliciting bids under solicitation J28030 for statewide sample collection, initial drug screening, and confirmation testing. The contractor is responsible for collecting urine specimens from individuals referred by the First, Second, Third, and Fifth Circuit courts at their own or an approved subcontractor's facilities. Initial screenings must utilize the EMIT system or an approved equivalent, while confirmation testing must be performed using gas chromatography/mass spectrometry by a company licensed and accredited in Hawaii. The contractor must provide these services seven days a week and submit written procedures to the Officer-in-Charge to ensure samples are not tampered with during collection. The contract is for an initial twenty-four month term from July 1, 2027, through June 30, 2029, with the possibility of two additional twelve-month extensions. Award will be granted to the lowest responsive and responsible bidder, with preferences considered for Hawaii-based products and other statutory categories. Payment is based on the actual number of samples collected per month at the unit bid cost, with invoices submitted separately for each circuit. The contractor must maintain compliance with various Hawaii state laws, including tax clearances, unemployment insurance, and prepaid health care requirements.
Department of Judiciary

POSTED

about 15 hours ago

DEADLINE

in 25 days
View Details
NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is soliciting quotes for a one-time purchase of antibiotics to be stockpiled for post-exposure response to Category A agents, including anthrax, plague, and tularemia. The requirement consists of 30,000 tablets of Ciprofloxacin Hydrochloride (500mg/dose) and 200,000 tablets of Doxycycline Monohydrate (100mg/dose). All products must be FDA approved and comply with CDC and California Department of Public Health standards. Strict adherence to cold-chain storage and temperature-controlled guidelines is required, with the use of temperature-monitoring devices during transit and full lot-level traceability from production to delivery. The contract must be completed within the city's fiscal year ending June 30, 2027, with a required delivery lead time of four business days from the date of order to the delivery location at 1845 N Fair Oaks Ave, Pasadena, CA. Bidders must submit pricing electronically via the city's eProcurement Portal, ensuring that quoted unit prices include all delivery costs and sales tax, as no separate freight or handling fees will be accepted. The response deadline is November 4, 2026. Compliance requirements include the submission of a Unique Entity Identifier (UEI), IRS Form W-9, and various vendor questionnaires regarding equal opportunity and legal status. The procurement is subject to federal regulations, including FEMA terms and conditions, the Davis-Bacon Act for prevailing wages, and the Byrd Anti-Lobbying Amendment. Award will be based on the ability to deliver the specified antibiotics at a competitive price while meeting all regulatory, insurance, and technical specifications.
Public Health Department

POSTED

about 16 hours ago

DEADLINE

in 6 days
View Details